SuperworthLantheus market cap LNTH
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $6.5B
- Highest close in our data
- $8.6B
- Jul 2024
Lantheus is worth $6.5B at the close on Oct 23, 2026, at $99.80 a share.
That is up 71% over the last year and up 312% over five years.
Its highest close in our data was $8.6B in Jul 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6.5B | $4.3B | $7.2B | +47% |
| 2025 | $4.4B | $3.4B | $7.4B | −31% |
| 2024 | $6.4B | $3.6B | $8.6B | +51% |
| 2023 | $4.2B | $3.3B | $6.8B | +21% |
| 2022 | $3.5B | $1.7B | $5.8B | +79% |
| 2021 | $2B | $991M | $2.1B | +117% |
| 2020 | $902.1M | $405.9M | $993M | +13% |
| 2019 | $795.6M | $603.9M | $1.1B | +38% |
| 2018 | $578.1M | $494.1M | $885.1M | −25% |
| 2017 | $767M | $294.7M | $851.4M | +150% |
| 2016 | $307.2M | $59.2M | $351.9M | +189% |
| 2015 | $106.4M | $92.6M | $229.3M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Lantheus' size, closest first, today.
| Company | Market cap |
|---|---|
| LNTHLantheus | $6.5B |
| BLLNBillionToOne | $5.1B |
| CAICaris Life Sciences | $9B |
| BIOBio-Rad Laboratories | $9.9B |
| VCYTVeracyte | $3.9B |
| CDNACareDx | $3.6B |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| MTDMettler-Toledo International | $33.5B |
| Peer median | $13.8B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Lantheus
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.